Regulatory Services
Trusted global expertise for regulatory success in life sciences.
QNova LifeSciences delivers comprehensive regulatory services for biotechnology, pharmaceutical, and medical device innovators. With decades of experience and hundreds of successful FDA and EMA approvals, we help clients:
- Build and execute tailored regulatory strategies
- Navigate complex and evolving compliance requirements
- Achieve faster, more predictable approvals
- Reduce risk at every stage of development
Our record speaks for itself:
- 30+ FDA Special Designations granted
- 65+ NDA, BLA, and 505(b)(1)/(b)(2) approvals
- 250+ successful FDA Class I & II medical device submissions (100% success rate)
- 500+ therapeutic projects supported
Introduction to Regulatory Services
The regulatory environment is no longer a “checkbox” exercise — it is a core driver of commercial success. Each stage of development is closely tied to regulatory milestones that influence funding, partnerships, and market access. Companies that plan early and engage experts can avoid common pitfalls, accelerate development, and strengthen their investor story.
Global frameworks are expanding, with new requirements across:
- Pharmaceuticals (NDA, BLA, ANDA, clinical trial regulations)
- Medical Devices & Diagnostics (MDR, IVDR, FDA 510(k), De Novo, PMA)
QNova provides end-to-end services that integrate strategy, submissions, compliance, and quality systems into one coherent framework. Whether you are a start-up preparing for IND or a multinational seeking global lifecycle management, we tailor solutions to your needs.
Learn more about How We Work
Why Regulatory Services Matter
A strong regulatory foundation is critical for both patient safety and business success. Authorities worldwide are continuously raising expectations, making it vital to plan proactively. Companies that underestimate regulatory requirements often face clinical holds, deficiency letters, or recalls — issues that can derail development and damage reputations.
At the same time, a robust regulatory strategy is a competitive advantage. It enables faster approvals, improves investor confidence, and increases the likelihood of securing partnerships or designations that shorten timelines.
- Increasing regulatory complexity: From U.S. FDA to EU EMA and Asia-Pacific authorities, regulatory expectations are evolving rapidly.
- Market trust & patient safety: Compliance builds credibility with investors, payers, and patients.
- Risk of failure: Missed requirements can lead to costly recalls, approval delays, or reputational harm.
- Competitive advantage: Companies that integrate compliance early not only reach patients faster but also create sustainable growth.
Our Regulatory Services
We provide end-to-end regulatory support covering every stage of the product lifecycle. From early development roadmaps to global submissions and post-market compliance, our services are designed to reduce uncertainty and accelerate success.
Strategy & Compliance
Successful approvals begin with a clear regulatory strategy. We provide risk-based regulatory strategy development, ensuring every decision aligns with agency expectations and commercial goals. Services include:
- Regulatory roadmaps from preclinical to commercialization
- Gap analyses (CMC, nonclinical, clinical)
- Lifecycle planning for IND, CTA, NDA, ANDA, BLA, MAA submissions
- Short- and long-term project-based consulting support
- Ongoing compliance monitoring across jurisdictions
Pharmaceuticals & Healthcare Regulatory Services
Drug and biologic development requires deep knowledge of evolving global frameworks. We have guided dozens of novel therapies through expedited pathways, major submissions, and complex regulatory negotiations. By working alongside clients, we streamline evidence generation and ensure submissions are complete, compliant, and persuasive.
QNova’s drug and biologic regulatory expertise spans early development through approval:
- IND, NDA, ANDA, BLA, and MAA submissions
- Orphan Drug, Fast Track, Breakthrough Therapy, and RMAT designations
- Clinical trial protocol alignment and regulatory briefing packages
- Global market entry strategy for medicines and advanced biologics
- Risk-benefit assessments and due diligence for investors and licensing deals
Explore our Drug Regulatory Solutions
Medical Devices & IVD Regulatory Services
Medical device and diagnostic regulations are among the most dynamic and demanding. Our device experts have a 100% success rate across 250+ FDA submissions, covering everything from traditional implants to AI-driven software. We guide innovators through classification, predicate selection, and global technical documentation.
Our services include:
- FDA 510(k), De Novo, and PMA submissions
- CE Marking and global expansion support
- IVDR compliance for diagnostics
- Medical device software, wearables, and AI-integrated systems
- Drug-device combination regulatory pathways
- Risk classification and predicate assessments
- ISO 13485 and 21 CFR Part 820-compliant QMS development
Explore our Medical Device Regulatory Services
Specialized Regulatory Support
Not every challenge fits into a standard submission pathway. We provide specialized services designed to de-risk regulatory interactions and resolve high-stakes issues. Our team includes former regulators and senior consultants who have managed hundreds of FDA and EMA meetings.
We offer targeted services to de-risk regulatory interactions and maintain compliance:
- FDA and EMA meeting preparation (Pre-IND, End of Phase, Pre-NDA/BLA, Pre-Sub, Scientific Advice)
- Regulatory communications and submission-ready briefing books
- U.S. FDA Agent representation for non-U.S. companies
- Ongoing monitoring of global regulatory changes
- Third-party liaison with regulators worldwide
Why Outsource Your Regulatory Services?
Building an in-house regulatory team can be costly and inflexible. By outsourcing to us, companies gain access to global expertise, proven frameworks, and scalable engagement models that adapt as development progresses.
Benefits include:
- Global expertise + local insight: We combine worldwide experience with local authority relationships.
- Cost-effective and scalable: Solutions tailored to small biotech or large pharma.
- Strategic independence: We provide unbiased, science-based regulatory advice.
- Accelerated time-to-market: Efficient submissions, reduced risk of agency pushback.
- Proven results: From IND submissions to post-market compliance, QNova has a track record of success.
Industries We Serve
We work across the entire life sciences ecosystem, tailoring regulatory strategies to the unique requirements of each sector. Our experience spans therapeutic innovation, medtech advancement, and nutrition-based products.
We serve:
- Pharmaceuticals & Biotechnology – NCEs, biologics, biosimilars, cell/gene therapies
- Medical Devices & IVDs – diagnostics, imaging, surgical tools, wearables, AI-enabled platforms
- Foods & Nutrition – supplements, GRAS determinations, medical foods
- Regenerative Therapies – advanced biologics, engineered tissues
Events & Publications
We share insights that help clients and partners stay ahead of evolving requirements. Our thought leadership is built to provide both strategic guidance and practical tools.
- Webinars on U.S. FDA and EU regulatory alignment
- Downloadable brochures and regulatory service guides
- Reports measuring ROI from regulatory innovation
Explore QNova Expertise
Why Choose QNova LifeSciences
Choosing a regulatory partner is a strategic decision. We combine global authority expertise, industry breadth, and personalized service to deliver results. Our clients trust us because we act as true partners — guiding programs from idea to approval and beyond.
- Proven Track Record: Over 500 projects, 250+ device submissions, 65+ major approvals
- Integrated Approach: Regulatory + clinical + quality + commercialization support
- Flexible Engagement: On-demand regulatory experts matched to your needs
- Global Coverage: FDA, EMA, MHRA, PMDA, Health Canada, NMPA, and more
- Commitment to Clients: One point of contact, milestone-based plans, and personalized strategy
Frequently Asked Questions
What are Regulatory Services?
End-to-end consulting, compliance, and submissions that ensure regulated products meet local and global requirements.
Does QNova provide medical device regulatory consulting?
Yes — with proven success in 510(k), De Novo, PMA, CE Marking, and global submissions.
Can QNova act as FDA Agent for foreign companies?
Yes — we represent non-U.S. companies before the FDA.
Explore Related Services
Build Your Regulatory Success
Build your regulatory success with QNova LifeSciences.
From strategic planning to global submissions, QNova ensures your innovations reach patients faster, with reduced risk and enhanced compliance.